V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20212761 | 20079335 | 1.84 | 78.9 | Palliative (P) | 2020-09-01 | 2020-09-06 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100079776 |
| 20212762 | 20079336 | 1.76 | 92 | Neo-adjuvant (N) | 2018-06-08 | 2018-06-22 | CAPECITABINE + CARBOPLATIN | 02 | N | CISPLATIN + FLUOROURACIL | 100070157 |
| 20212763 | 20079337 | 1.63 | 66 | Neo-adjuvant (N) | 2016-05-21 | 2016-06-06 | Cisplatin +Fluorouracil (2 wk) | N | N | CISPLATIN + FLUOROURACIL | 101586208 |
| 20212764 | 20079338 | null | null | Curative (C) | 2018-09-02 | 2018-09-08 | CAPECITABINE + CARBOPLATIN | 02 | N | DOXORUBICIN EMBOLISATION | 101183627 |
| 20212765 | 20079339 | 0 | 0 | Palliative (P) | 2018-04-26 | 2018-05-18 | Capecitabine (21days) + Carboplatin | 02 | N | DOXORUBICIN EMBOLISATION | 100111237 |
| 20212766 | 20079340 | 1.67 | 111.1 | null | 2018-12-25 | 2018-12-25 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100662592 |
| 20212767 | 20079341 | 1.76 | 71 | Neo-adjuvant (N) | 2019-06-17 | 2019-06-17 | Cisplatin + Fluorouracil + RT 5day | 02 | null | CISPLATIN + FLUOROURACIL | 100884740 |
| 20212769 | 20079342 | 1.64 | 60.8 | Palliative (P) | 2017-06-12 | 2017-06-12 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100916779 |
| 20212771 | 20079343 | null | 64 | Curative (C) | 2019-06-28 | 2019-07-26 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 101598199 |
| 20212772 | 20079344 | 1.59 | 57 | Curative (C) | 2017-06-24 | 2017-06-24 | CAPECITABINE + CARBOPLATIN | 02 | N | DOXORUBICIN EMBOLISATION | 100923902 |
| 20212773 | 20079345 | 1.74 | 64.1 | Neo-adjuvant (N) | 2017-03-25 | 2017-03-25 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100499537 |
| 20212774 | 20079346 | 1.68 | 94.6 | Palliative (P) | 2017-06-06 | 2017-06-07 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101057982 |
| 20212775 | 20079347 | 1.79 | 54 | null | 2019-01-12 | 2019-02-05 | CAPECITABINE + CARBOPLATIN | 02 | null | CISPLATIN + FLUOROURACIL | 101335856 |
| 20212776 | 20079348 | 1.52 | 79.8 | null | 2016-03-08 | 2016-03-30 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 100295952 |
| 20212779 | 20079349 | 1.85 | 72.9 | Neo-adjuvant (N) | 2018-03-29 | 2018-04-06 | CAPECITABINE + CARBOPLATIN | 02 | N | TRIAL UNSPECIFIED | 101079111 |
| 20212780 | 20079350 | 1.78 | 57.6 | 03 | null | 2017-07-01 | CAPECITABINE + CARBOPLATIN | 02 | null | TRIAL UNSPECIFIED | 101617063 |
| 20212781 | 20079351 | 1.69 | 74.8 | Neo-adjuvant (N) | 2017-03-24 | 2017-03-26 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100581247 |
| 20212783 | 20079352 | 1.85 | 100.6 | null | 2018-04-22 | 2018-05-10 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 100183131 |
| 20212784 | 20079353 | 1.66 | 50.7 | null | 2016-04-29 | 2016-04-29 | CAPECITABINE + CARBOPLATIN | 02 | null | CISPLATIN + FLUOROURACIL | 100374257 |
| 20212785 | 20079354 | 1.66 | 72 | Neo-adjuvant (N) | 2019-02-16 | 2019-02-19 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101274463 |
| 20212786 | 20079355 | 1.73 | 73 | null | 2020-03-08 | 2020-05-03 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100653173 |
| 20212787 | 20079356 | 1.79 | 66.2 | Curative (C) | 2020-02-23 | 2020-03-01 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100623072 |
| 20212789 | 20079357 | 1.5 | 65 | Neo-adjuvant (N) | 2017-05-06 | 2017-05-07 | CAPECITABINE + CARBOPLATIN | N | N | CAPECITABINE + CARBOPLATIN | 101664547 |
| 20212790 | 20079358 | 1.63 | 69.4 | Curative (C) | 2018-08-18 | 2018-08-29 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100628859 |
| 20212792 | 20079359 | 1.6 | 92.55 | Curative (C) | 2017-11-21 | 2017-11-21 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101865554 |
| 20212793 | 20079360 | 1.78 | 79.95 | Palliative (P) | 2018-12-10 | 2018-12-10 | Cisplatin +Fluorouracil (2 wk) | N | N | CISPLATIN + FLUOROURACIL | 100931615 |
| 20212794 | 20079361 | 1.77 | 45 | Palliative (P) | 2018-06-16 | 2018-07-13 | Cisplatin +Fluorouracil (2 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101807942 |
| 20212795 | 20079362 | 1.6 | 74 | Neo-adjuvant (N) | 2018-01-19 | 2018-01-19 | CAPECITABINE + CARBOPLATIN | 02 | null | TRIAL UNSPECIFIED | 100513015 |
| 20212797 | 20079363 | 1.76 | 100.2 | Neo-adjuvant (N) | 2018-06-19 | 2018-06-28 | Capecitabine (21days) + Carboplatin | N | N | TRIAL UNSPECIFIED | 100955240 |
| 20212798 | 20079364 | 1.76 | 56 | Curative (C) | 2017-05-07 | 2017-05-23 | Capecitabine + Carboplatin + RT | 02 | null | CAPECITABINE + CARBOPLATIN | 101792909 |
| 20212799 | 20079365 | 1.8 | 63 | 03 | 2018-03-27 | 2018-04-17 | CISPLATIN + FLUOROURACIL + RT | null | null | CISPLATIN + FLUOROURACIL | 100062283 |
| 20212800 | 20079366 | null | 87.5 | 03 | 2017-05-24 | 2017-05-24 | Capecitabine (21days) + Carboplatin | 02 | null | DOXORUBICIN EMBOLISATION | 100692499 |
| 20212802 | 20079367 | 1.8 | 70 | Neo-adjuvant (N) | 2017-05-11 | 2017-05-27 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101665287 |
| 20212803 | 20079368 | 1.75 | 51.7 | 03 | 2018-02-24 | 2018-02-24 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 101447717 |
| 20212805 | 20079369 | 1.62 | 92.55 | 03 | 2018-03-14 | 2018-03-18 | Capecitabine + Carboplatin + RT | 02 | N | CAPECITABINE + CARBOPLATIN | 100335641 |
| 20212806 | 20079370 | 1.81 | 95.2 | Palliative (P) | 2017-05-19 | 2017-06-06 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100833689 |
| 20212807 | 20079371 | 1.9 | 63.4 | Neo-adjuvant (N) | null | 2019-09-27 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101713951 |
| 20212808 | 20079372 | 1.66 | 99 | null | 2016-06-22 | 2016-07-13 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101017301 |
| 20212809 | 20079373 | 1.85 | 47.5 | Palliative (P) | 2017-11-18 | 2017-11-25 | Capecitabine (21days) + Carboplatin | 02 | N | TRIAL UNSPECIFIED | 100280273 |
| 20212811 | 20079374 | 1.66 | 95.25 | Curative (C) | 2019-07-16 | 2019-07-16 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101452593 |
| 20212812 | 20079375 | 0 | 0 | Palliative (P) | 2016-03-09 | 2016-04-01 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101069053 |
| 20212813 | 20079376 | 1.48 | 98.8 | Palliative (P) | 2017-11-10 | 2017-11-18 | CISPLATIN + FLUOROURACIL + RT | 02 | N | CISPLATIN + FLUOROURACIL | 101603997 |
| 20212814 | 20079377 | 1.57 | 96 | Neo-adjuvant (N) | 2018-05-13 | 2018-05-16 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101250050 |
| 20212816 | 20079378 | 1.66 | 80.4 | null | 2019-10-11 | 2019-10-11 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100469966 |
| 20212817 | 20079379 | 1.59 | 81.9 | Curative (C) | 2017-04-25 | 2017-05-23 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 101722630 |
| 20212818 | 20079380 | 1.88 | 54.7 | null | 2018-09-03 | 2018-09-30 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101609001 |
| 20212819 | 20079381 | 1.48 | 82.9 | 03 | 2016-06-30 | 2016-07-13 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 100307239 |
| 20212820 | 20079382 | 1.67 | 54 | Palliative (P) | 2019-07-05 | 2019-07-08 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100788170 |
| 20212824 | 20079383 | 1.68 | 57.5 | 03 | 2017-07-27 | 2017-08-08 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101229325 |
| 20212826 | 20079384 | 1.73 | 57.4 | Curative (C) | 2018-07-29 | 2018-08-21 | Capecitabine (21days) + Carboplatin | 02 | N | TRIAL UNSPECIFIED | 100243583 |